Insulet ’s PODD robust execution to expand the Omnipod 5 platform globally is a tailwind. The company is also capitalizing on ...

Stay up to date with all our business news: sign up to our Business Today daily email news digest. If you’d like to read more ...

In the past year, this Zacks Rank #2 (Buy) stock has increased 67.8% compared ... hinted at launching the Omnipod 5 with Abbott’s Freestyle Libre 2 Plus sensor in the United States by the ...

The device is similar to Abbott’s FreeStyle Libre, which people with diabetes ... But first, people have to buy the devices. “You’ve got to think about who can afford $89 or $99 a month ...

The device is similar to Abbott’s FreeStyle Libre, which people with diabetes have been using ... But first, people have to ...

Health care apps like MyChart, mySugr, GoodRx, and Smoke Free can enhance patient care through accessibility, convenience, ...

If a company's history and track record were good enough reasons to buy its shares ... franchise, the FreeStyle Libre. Over the past few years, this product line has been Abbott's most important ...

ABT appears fairly valued, showing no strong buy or sell signals based on its ... Notably, sales of the FreeStyle Libre, the popular glucose scanning device has contributed $1.6 billion in the ...